Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: A new potential biomarker for atherosclerosis

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 20-29

  De Gonzalo Calvo, D ^a   Cenarro, A ^b   Martinez Bujidos M ^c   Badimon, L ^a   Bayes Genis, A ^d   Ordonez Llanos, J ^c,e   Civeira, F ^b   Llorente Cortes V ^a  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Atherosclerosis; Biomarker; Hypercholesterolemia; Soluble low density lipoprotein receptor related protein 1; Vascular smooth muscle cell

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; BIOLOGICAL MARKER; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SIMVASTATIN; SOLUBLE LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 1; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LRP1 PROTEIN, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; EX VIVO STUDY; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VASCULAR SMOOTH MUSCLE CELL; ATHEROSCLEROSIS; BLOOD; CELL CULTURE; METABOLISM; MIDDLE AGED; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE; YOUNG ADULT;

ADULT; AGED; ATHEROSCLEROSIS; BIOMARKERS; CELLS, CULTURED; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; YOUNG ADULT;

EID: 84943569585     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.085     Document Type: Article

References (70)

1. B.J. Arsenault, S.M. Boekholdt, and J.J. Kastelein Lipid parameters for measuring risk of cardiovascular disease Nat. Rev. Cardiol. 8 2011 197 206
2. E. Di Angelantonio, N. Sarwar, P. Perry, and et al. Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
3. D. Khalili, S. Asgari, F. Hadaegh, and et al. A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: a population-based study Int. J. Cardiol. 184 2015 587 594
4. B.J. Arsenault, J.S. Rana, E.S. Stroes, and et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women J. Am. Coll. Cardiol. 55 2009 35 41
5. E. Di Angelantonio, P. Gao, L. Pennells, and et al. Lipid-related markers and cardiovascular disease prediction JAMA 307 2012 2499 2506
6. J.J. Kastelein, W.A. van der Steeg, I. Holme, and et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment Circulation 117 2008 3002 3009
7. R. Cal, O. Juan-Babot, V. Brossa, and et al. Low density lipoprotein receptor-related protein 1 expression correlates with cholesteryl ester accumulation in the myocardium of ischemic cardiomyopathy patients J. Transl. Med. 10 2012 160
8. K. Handschug, S. Schulz, C. Schnurer, and et al. Low-density lipoprotein receptor-related protein in atherosclerosis development: up-regulation of gene expression in patients with coronary obstruction J. Mol. Med. (Berl.) 76 1998 596 600
9. V. Llorente-Cortés, M. Otero-Viñas, S. Camino-López, and et al. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells Circulation 110 2004 452 459
10. V. Llorente-Cortés, M. Otero-Viñas, S. Sánchez, and et al. Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism Circulation 106 2002 3104 3110
11. J. Luoma, T. Hiltunen, T. Sarkioja, and et al. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions J. Clin. Invest. 93 1994 2014 2021
12. V. Llorente-Cortés, L. Casani, R. Cal, and et al. Cholesterol-lowering strategies reduce vascular LRP1 overexpression induced by hypercholesterolaemia Eur. J. Clin. Investig. 41 2011 1087 1097
13. V. Llorente-Cortés, M. Otero-Viñas, M. Berrozpe, and et al. Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries Eur. J. Clin. Investig. 34 2004 182 190
14. T.P. Hiltunen, J.S. Luoma, T. Nikkari, and et al. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development Circulation 97 1998 1079 1086
15. J. Sendra, V. Llorente-Cortés, P. Costales, and et al. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension Cardiovasc. Res. 78 2008 581 589
16. B.L. Rosa, L.C. Vicenta, G.C. Victor, and et al. Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes Cardiovasc. Diabetol. 11 2012 86
17. K. Oorni, M.O. Pentikainen, M. Ala-Korpela, and et al. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res. 41 2000 1703 1714
18. V. Llorente-Cortés, M. Otero-Viñas, and L. Badimon Differential role of heparan sulfate proteoglycans on aggregated LDL uptake in human vascular smooth muscle cells and mouse embryonic fibroblasts Arterioscler. Thromb. Vasc. Biol. 22 2002 1905 1911
19. V. Llorente-Cortés, M. Otero-Viñas, S. Camino-López, and et al. Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 26 2006 117 123
20. V. Llorente-Cortés, T. Royo, O. Juan-Babot, and et al. Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages J. Lipid Res. 48 2007 2133 2140
21. P. Costales, R. Aledo, S. Vernia, and et al. Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression Atherosclerosis 213 2010 458 468
22. V. Llorente-Cortés, P. Costales, J. Bernues, and et al. Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription J. Mol. Biol. 359 2006 950 960
23. S. Allahverdian, A.C. Chehroudi, B.M. McManus, and et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis Circulation 129 2014 1551 1559
24. Q. Liu, J. Zhang, H. Tran, and et al. LRP1 shedding in human brain: roles of ADAM10 and ADAM17 Mol. Neurodegener. 4 2009 17
25. K.A. Quinn, P.G. Grimsley, Y.P. Dai, and et al. Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma J. Biol. Chem. 272 1997 23946 23951
26. M. Wygrecka, J. Wilhelm, E. Jablonska, and et al. Shedding of low-density lipoprotein receptor-related protein-1 in acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 184 2011 438 448
27. K.A. Quinn, V.J. Pye, Y.P. Dai, and et al. Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP) Exp. Cell Res. 251 1999 433 441
28. R. Polavarapu, M.C. Gongora, H. Yi, and et al. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit Blood 109 2007 3270 3278
29. C.A. von Arnim, A. Kinoshita, I.D. Peltan, and et al. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate J. Biol. Chem. 280 2005 17777 17785
30. C. Selvais, L. D'Auria, D. Tyteca, and et al. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function Faseb J. 25 2011 2770 2781
31. V. Llorente-Cortés, J. Martínez-González, and L. Badimon Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors Arterioscler. Thromb. Vasc. Biol. 18 1998 738 746
32. V. Llorente-Cortés, J. Martínez-González, and L. Badimon LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 20 2000 1572 1579
33. M. Prokopi, G. Pula, U. Mayr, and et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures Blood 114 2009 723 732
34. V. Llorente-Cortés, M. Otero-Viñas, E. Hurt-Camejo, and et al. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors Arterioscler. Thromb. Vasc. Biol. 22 2002 387 393
35. J.A. Gómez-Gerique, J.A. Gutierrez-Fuentes, M.T. Montoya, and et al. Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group Med. Clin. (Barc.) 113 1999 730 735
36. E. Jarauta, R. Mateo-Gallego, R. Gilabert, and et al. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia Nutr. Metab. Cardiovasc. Dis. 22 2012 591 597
37. J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
38. L. Nasarre, O. Juan-Babot, P. Gastelurrutia, and et al. Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels Acta Diabetol. 15 2014 23 30
39. A.V. Sima, G.M. Botez, C.S. Stancu, and et al. Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress J. Cell. Mol. Med. 14 2010 2790 2802
40. S.M. Hofmann, L. Zhou, D. Perez-Tilve, and et al. Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice J. Clin. Invest. 117 2007 3271 3282
41. O. Masson, C. Chavey, C. Dray, and et al. LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue PLoS One 4 2009 e7422
42. P. May The low-density lipoprotein receptor-related protein 1 in inflammation Curr. Opin. Lipidol. 24 2013 134 137
43. M. Gorovoy, A. Gaultier, W.M. Campana, and et al. Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages J. Leukoc. Biol. 88 2010 769 778
44. P. Costales, J. Castellano, E. Revuelta-López, and et al. Lipopolysaccharide downregulates CD91/low-density lipoprotein receptor-related protein 1 expression through SREBP-1 overexpression in human macrophages Atherosclerosis 227 2013 79 88
45. R. Cal, J. Castellano, E. Revuelta-López, and et al. Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes Cardiovasc. Res. 94 2012 469 479
46. M.M. Veniant, C.H. Zlot, R.L. Walzem, and et al. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice J. Clin. Invest. 102 1998 1559 1568
47. V. Llorente-Cortés, T. Royo, M. Otero-Viñas, and et al. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages Cardiovasc. Res. 74 2007 526 536
48. A.S. Haka, I. Grosheva, E. Chiang, and et al. Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins Mol. Biol. Cell 20 2009 4932 4940
49. S. Selvarajah, G. Kaur, J. Haniff, and et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population Int. J. Cardiol. 176 2014 211 218
50. B. Zethelius, L. Berglund, J. Sundstrom, and et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N. Engl. J. Med. 358 2008 2107 2116
51. S.M. Boekholdt, B.J. Arsenault, S. Mora, and et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis JAMA 307 2012 1302 1309
52. R.C. Hoogeveen, J.W. Gaubatz, W. Sun, and et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study Arterioscler. Thromb. Vasc. Biol. 34 2014 1069 1077
53. P.R. Kamstrup, A. Tybjaerg-Hansen, and B.G. Nordestgaard Extreme lipoprotein(a) levels and improved cardiovascular risk prediction J. Am. Coll. Cardiol. 61 2013 1146 1156
54. R.H. Mackey, P. Greenland, D.C. Goff Jr., and et al. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis) J. Am. Coll. Cardiol. 60 2012 508 516
55. M.J. McQueen, S. Hawken, X. Wang, and et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study Lancet 372 2008 224 233
56. S. Mora, R.J. Glynn, S.M. Boekholdt, and et al. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin) J. Am. Coll. Cardiol. 59 2012 1521 1528
57. K.K. Ray, C.P. Cannon, R. Cairns, and et al. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 Arterioscler. Thromb. Vasc. Biol. 29 2009 424 430
58. J.G. Robinson, S. Wang, and T.A. Jacobson Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials Am. J. Cardiol. 110 2012 1468 1476
59. A. Varbo, M. Benn, A. Tybjaerg-Hansen, and et al. Remnant cholesterol as a causal risk factor for ischemic heart disease J. Am. Coll. Cardiol. 61 2013 427 436
60. 64Cu]-labeled scavenger receptor (CD68-Fc) Int. J. Cardiol. 177 2014 287 291
61. S.S. Virani, D.J. Catellier, L.A. Pompeii, and et al. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study Atherosclerosis 219 2011 596 602
62. A.V. Khera, M. Cuchel, M. de la Llera-Moya, and et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2011 127 135
63. A. Rohatgi, A. Khera, J.D. Berry, and et al. HDL cholesterol efflux capacity and incident cardiovascular events N. Engl. J. Med. 371 2014 2383 2393
64. A. Handberg, K. Levin, K. Hojlund, and et al. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance Circulation 114 2006 1169 1176
65. A. Handberg, M. Skjelland, A.E. Michelsen, and et al. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability Stroke 39 2008 3092 3095
66. K. Hayashida, N. Kume, T. Murase, and et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis Circulation 112 2005 812 818
67. S.D. Scilabra, L. Troeberg, K. Yamamoto, and et al. Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1 J. Biol. Chem. 288 2013 332 342
68. C. Selvais, H.P. Gaide Chevronnay, P. Lemoine, and et al. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation Endocrinology 150 2009 3792 3799
69. A. Gaultier, S. Arandjelovic, X. Li, and et al. A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents J. Clin. Invest. 118 2008 161 172
70. A. Sagare, R. Deane, R.D. Bell, and et al. Clearance of amyloid-beta by circulating lipoprotein receptors Nat. Med. 13 2007 1029 1031